These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7250205)

  • 21. Changes in systemic haemodynamics, regional myocardial function and perfusion induced by alinidine in pigs with and without narrowed coronary arteries.
    Verdouw PD; Duncker DJ; Heere TJ; Saxena PR
    Eur Heart J; 1987 Dec; 8 Suppl L():43-52. PubMed ID: 3451882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific bradycardic agents--a novel pharmacological class?
    Kobinger W; Lillie C
    Eur Heart J; 1987 Dec; 8 Suppl L():7-15. PubMed ID: 2897916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions of two new bradycardic agents, AQ-AH 208 and UL-FS 49, on ischemic myocardial perfusion and function.
    Dämmgen JW; Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1985; 7(1):71-9. PubMed ID: 2580154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac electrophysiological effects of falipamil in the conscious dog: comparison with alinidine.
    Boucher M; Chassaing C; Chapuy E
    Eur J Pharmacol; 1996 Jun; 306(1-3):93-8. PubMed ID: 8813620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of AQ-A 39 in healthy volunteers.
    Hilaire J; Broustet JP; Colle JP; Theron M
    Br J Clin Pharmacol; 1983 Dec; 16(6):627-31. PubMed ID: 6661346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.
    Lillie C; Kobinger W
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):331-3. PubMed ID: 3587375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental evidence for the antiarrhythmic action of indoramin.
    Harron DW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S131-6. PubMed ID: 2423786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradycardic effect of alinidine on in situ and on isolated, blood-perfused heart preparations of dogs.
    Ogiwara Y; Furukawa Y; Saegusa K; Takeda M; Chiba S
    Arch Int Pharmacodyn Ther; 1988; 291():41-54. PubMed ID: 2835022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49.
    Doerr T; Trautwein W
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):331-40. PubMed ID: 1692108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of AQ-A39, a bradycardic agent, on cardiovascular responses to isoproterenol in the anesthetized dog.
    Wenger HC; Siegl PK
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):246-53. PubMed ID: 2436007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alinidine as a model of the mode of action of specific bradycardic agents on SA node activity.
    van Ginneken AC; Bouman LN; Jongsma HJ; Duivenvoorden JJ; Opthof T; Giles WR
    Eur Heart J; 1987 Dec; 8 Suppl L():25-33. PubMed ID: 3451880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
    Gout B; Jean J; Bril A
    J Pharmacol Exp Ther; 1992 Sep; 262(3):987-94. PubMed ID: 1527735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AQA 39*, a new bradycardic agent which blocks myocardial calcium (Ca) channels in a frequency- and voltage-dependent manner.
    Trautwein W; Pelzer D; McDonald TF; Osterrieder W
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):228-32. PubMed ID: 6275277
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bradycardic agents on ischaemic myocardium and perfusion in anesthetized dogs.
    Gross GJ; Daemmgen JW
    Eur Heart J; 1987 Dec; 8 Suppl L():69-74. PubMed ID: 3451885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing.
    Verdouw PD; Saxena PR; Schamhardt HC; van der Hoek TM; Rutteman AM
    Eur J Pharmacol; 1980 Jun; 64(4):209-20. PubMed ID: 7389819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of falipamil (AQ-A 39) on heart rate and blood pressure in resting and exercising healthy volunteers.
    Naudascher M; Jaillon P; Lecocq B; Lecocq V; Ferry A; Hilaire J; Maria JF
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):1-5. PubMed ID: 2475699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and dynamic effects of diltiazem in the isolated guinea-pig heart.
    Jensen HK; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):166-71. PubMed ID: 3375187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.
    Pérez O; Gay P; Franqueza L; Carrón R; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.